OOIR: Observatory of International Research

Papers

(The H4-Index of New England Journal of Medicine is 252. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Race in Medicine — Genetic Variation, Social Categories, and Paths to Health Equity	3017
Hyperpigmentation in Vitamin B ₁₂ Deficiency	2699
Code Switch	2387
Tenecteplase for Stroke — Opening the Window?	2287
Designing Cures 2.0 — From Corridors to Cornerstones	2145
Adrenal Involvement in Disseminated Histoplasmosis	1921
Nasal Cauterization with Silver Nitrate for Recurrent Epistaxis	1838
Preparing for the Next Pandemic — Expanding and Coordinating Global Regulatory Capacity	1817
Black Dot Tinea Capitis	1685
Misogyny in Medicine	1602
U.S. Law and Discrimination in Health Care	1574
Hemotympanum with a Basilar Skull Fracture	1554
Multicentric Reticulohistiocytosis	1542
Alteplase and Thrombectomy — Not a Bridge to Dismantle	1534
Bismuth Subsalicylate Poisoning	1532
Hiding in Plain Sight	1468
Convalescent Rash of Dengue	1299
Foreign-Body Aspiration in a Child	1221
Nonketotic Hyperglycemic Hemichorea	1221
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD	1217
STEP 1 for Effective Weight Control — Another First Step?	1215
Testing for Arginine Vasopressin Deficiency	1193
HIPAA at 25 — A Work in Progress	1143
Use of Polygenic Scores to Select Embryos	1109
Ten Years of Incidental, Secondary, and Actionable Findings	1109

Investigating Injustices in the Journal ’s History, Part 2	1088
Paget’s Disease of the Breast	1079
Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors	1039
Poet as Patient	1034
Liver Transplantation for Mahvash Disease, an Inborn Error of Metabolism	1008
Modifiable Risk Factors and Cardiovascular Outcomes	985
Race-Based Diagnosis, Part 1 — ITT Episode 33	971
Primaquine and Plasmodium vivax Malaria Recurrence in Brazil	969
Childhood Risk Factors and Adult Cardiovascular Events	962
Ruxolitinib for Chronic Graft-versus-Host Disease	953
Maintenance or Discontinuation of Antidepressants in Primary Care	925
Case 40-2022: A 38-Year-Old Man with Exertional Chest Discomfort	896
Audio Interview: Assessing Bivalent Vaccines against Covid-19	893
Early Active Mobilization during Mechanical Ventilation in the ICU	871
Screening for Prostate Cancer	853
A Modern Therapy for an Ancient Disease	817
The Muffin Question	807
Audio Interview: Dissecting the Host Response to SARS-CoV-2	772
Bumps in the Road	769
Early Treatment with Sotrovimab for Covid-19	765
Gingival Infiltration in Acute Monocytic Leukemia	763
Covid-19 Infections in Vaccinated Health Care Workers	763
Perioperative Durvalumab in Bladder Cancer	736
Bilothorax	723
Postacute Sequelae of SARS-CoV-2 Infection in Several Eras	718
SENIOR-RITA — Is It All about Angiography?	715
Targeting CSF1R in Chronic GVHD — Lessons in Translation	712
Freedom of Speech	708
Rethinking Shadowing for Aspiring Physicians	696
Psychosocial Functioning in Transgender Youth after 2 Years of Hormones	695
Ménétrier’s Disease	693
Middle Meningeal Artery Embolization for Subdural Hematoma	688
Evidence-Based Work Design — Bridging the Divide	660
Monoclonal Antibodies for Malaria	655
Prolonging Cellular Life after Hypoxic Death	644
The Importance of Context in Covid-19 Vaccine Safety	643
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure	641
A Swell Diagnosis	626
Nationwide, Couple-Based Genetic Carrier Screening	626
Out of Pocket Getting Out of Hand — Reducing the Financial Toxicity of Rapidly Approved Drugs	615
Timing Is Everything — Evidence for When to Perform Complete Revascularization in STEMI	614
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia	613
How Can We Fully Realize SNAP’s Health Benefits?	610
Navigating and Communicating about Serious Illness and End of Life	600
Threatening the Future of Global Health — NIH Policy Changes on International Research Collaborations	596
Zilebesiran for Hypertension	591
Breaking the Sacred Promise	591
Empagliflozin in Heart Failure with a Preserved Ejection Fraction	589
Vaccine Breakthrough Infections with SARS-CoV-2 Variants	587
Mucosal IgA against SARS-CoV-2 Omicron Infection	582

Catching Up on REMs	580
Optical Coherence Tomography and Eye Care	580
Malnutrition in Adults	577
Receipt of mRNA Vaccine against Covid-19 and Myocarditis	577
Turning CMS into a Health Technology Assessment Organization	574
Gantenerumab in Early Alzheimer’s Disease	573
Kidney Injury and Hair-Straightening Products Containing Glyoxylic Acid	562
Reteplase versus Alteplase for Acute Ischemic Stroke	557
Use of Wastewater for Mpox Outbreak Surveillance in California	555
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B	554
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer	553
Nutritional Support for Moderate-to-Late–Preterm Infants — A Randomized Trial	529
Secondary Hypertrophic Osteoarthropathy	529
Haloperidol for the Treatment of Delirium in ICU Patients	528
Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam	528
Automatic Insurance Policies — Important Tools for Preventing Coverage Loss	524
Implanted System for Orthostatic Hypotension in Multiple-System Atrophy	523
From the Eyeball Test to the Algorithm — Quality of Life, Disability Status, and Clinical Decision Making in Surgery	514
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR	514
Navigating and Communicating about Serious Illness and End of Life	512
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia	512
Gastric Emptying Abnormalities in Diabetes Mellitus	511
Racial Inequality in Prescription Opioid Receipt — Role of Individual Health Systems	506
Bronchiectasis — A Clinical Review	502
Lung Transplantation for Covid-19–Related Respiratory Failure in the United States	502
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer	498
Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections	496
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma	495
Hypothermia or Machine Perfusion in Kidney Donors	490
Pulse Oximetry for Monitoring Patients with Covid-19 at Home — A Pragmatic, Randomized Trial	489
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype	489
Gazing into a Crystal Ball	483
Cholelithiasis, Cholecystitis, and Choledocholithiasis	482
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile	479
Periprosthetic Joint Infection	476
New Horizons in the Treatment of Osteosarcoma	476
Striving for Diversity in Research Studies	472
Fever of Unknown Origin	471
Virotherapy for Brain Tumors — Defining the Path to Success	467
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction	465
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer	463
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts	463
A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?	450
Case 38-2024: A 22-Year-Old Woman with Headache, Fever, and Respiratory Failure	448
Disappearing Data at the U.S. Federal Government	448
HIV Prevention and the 340B Drug Pricing Program	447
Personality Disorders	445
Case 39-2023: A 43-Year-Old Woman with Chronic Diarrhea, Hair Loss, and Nail and Skin Changes	437
Vocal-Cord Polyp Causing Airway Obstruction	433
Covid-19 Surveillance Testing in Nursing Homes	430
Audio Interview: Ending the Covid-19 Public Health Emergency	429
Case 26-2022: A 48-Year-Old Woman with Cystic Lung Disease	424
Audio Interview: Rolling Out New Covid-19 Vaccines	423
What We Don’t Know about School Shooter Drills	416
Case 21-2023: A 61-Year-Old Man with Eyelid Swelling	414
Water-Based and Waterless Surgical Scrub Techniques	413
Convalescent Plasma for Covid-19–Induced ARDS	412
Chylothorax	409
Gastric Syphilis	407
Routine Removal of Inferior Vena Cava Filters	406
HIPAA and the Leak of “Deidentified” EHR Data	403
What’s in a Number? Breaking Down the Residency Match Rate	401
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center	401
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction	399
Expect With Me — Group Prenatal Care to Reduce Disparities	398
Audio Interview: The Omicron Variant of SARS-CoV-2	397
Pretomanid in the Treatment of Patients with Tuberculosis in the United States	394
Compared with What? Measuring AI against the Health Care We Have	393
Medication-Associated Diethylene Glycol Mass Poisoning — A Preventable Cause of Illness and Death	391
Immune Checkpoint Inhibitors — The Need for Innovation	390
FINEARTS-HF — The Latest Masterpiece for MRAs in Heart Failure	390
The IARC Perspective on Cervical Cancer Screening	385
Dermatomyositis	382
Transfusion Strategy in Myocardial Infarction and Anemia	379
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use	378
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19	373
“Putting America First” — Undermining Health for Populations at Home and Abroad	370
Monkeypox	369
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer	369
Skeletal Fluorosis	366

SGLT2 Inhibitors and False Positive Toxicology Tests	365
Plasma Therapy to Prevent Severe Covid-19 in Older Adults	365
Criminalizing Homelessness — The Grants Pass, Oregon, Supreme Court Case	365
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6	362
Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia	361
The Risks of Normalizing Parental Vaccine Hesitancy	360
Behçet’s Syndrome	358
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease	358
Laryngeal Candidiasis	358
Broken Both Ways	353
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells	352
Guidance on Energy and Macronutrients across the Life Span	352
The Increasing Incidence of Early-Onset Colorectal Cancer	351
The Death of an Unlikable Man	350
Felzartamab in Antibody-Mediated Rejection	349
Medication for Gastroesophageal Reflux Disease in Infants	349
Invasive Strategy for Older Patients with MI	347
Making Long-Term Oxygen Therapy Less Burdensome	347
Increasing Firearm-Related Deaths among U.S. Black Rural Youths	345
Intravenous Amino Acids and Kidney Protection	345
Diagnostic Aspirations	344
Transforming Management of Opioid Use Disorder with Universal Treatment	343
Postherpetic Abdominal Pseudohernia	342
Mycoplasma-Induced Rash and Mucositis	342
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis — Past, Present, and Future	342
End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations	340
Cholesterol Pericarditis	340
Focused Cardiac Ultrasonography for Right Ventricular Size and Systolic Function	339
Academic Freedom in America — In Support of Institutional Voices	339
Genital Herpes Zoster	334
Pegylated Interferon Lambda for Covid-19	332
Crinecerfont in Adult Congenital Adrenal Hyperplasia	332
Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours	329
Benefits and Risks of Iron Interventions in Infants in Bangladesh	328
Ferning in Nasal Mucus	328
Public Health’s Role in a Post- Dobbs World — The New York City Abortion Access Hub	327
Autoantibodies Targeting Nephrin in Podocytopathies	326
Management of Recurrent Acute Otitis Media	325
Japanese Spotted Fever	321
Genetically Modified Porcine-to-Human Cardiac Xenotransplantation	321
Gustatory Hyperhidrosis after Parotid Surgery	318
Hospital Problems	314
Guilty	313
Moving the Needle on Alzheimer’s Disease with an Anti-Oligomer Antibody	312
Atrial Fibrillation — What Is It and How Is It Treated?	312
Targeting HER2 -Mutant NSCLC — The Light Is On	311
Audio Interview: Ending the Covid-19 Emergency	311
Booster Doses and Prioritizing Lives Saved	307
Case 5-2023: A 67-Year-Old Man with Interstitial Lung Disease, Fever, and Myalgias	306
A Dual-Chamber Leadless Pacemaker	302
Betibeglogene Autotemcel Gene Therapy for Non–β ⁰ /β ⁰ Genotype β-Thalassemia	299
A Zoonotic Henipavirus in Febrile Patients in China	298
Trials for Managing Acute Pain — A Clinically Meaningful Small Effect Size?	297
Methylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial	297
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial	295
Aspergillus Infections	294
Chronic Traumatic Encephalopathy in the Brains of Military Personnel	294
Bivalent Covid-19 Vaccines — A Cautionary Tale	293
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas	293
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy	291
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B	290
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes	287
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis	287
Helicobacter pylori , Homologous-Recombination Genes, and Gastric Cancer	287
Early Outpatient Treatment for Covid-19 with Convalescent Plasma	287
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults	286
Association between Covid-19 Vaccination and Influenza Vaccination Rates	284
Tuberculous Meningitis — New Approaches Needed	284
Cardiac Implantable Electronic Devices	283
Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease	283
Emodepside for Trichuris trichiura and Hookworm Infection	282
Advanced HIV as a Neglected Disease	281
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer	279
Dexamethasone and Surgical-Site Infection	278
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction	277
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis	277
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer	273
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency	273
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation	268
Minority Tax Reform — Avoiding Overtaxing Minorities When We Need Them Most	267
A Preview of the Dangerous Future of Abortion Bans — Texas Senate Bill 8	267
Vaccine Effectiveness Studies in the Field	267
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone	266
Autoantibodies Targeting Nephrin in Podocytopathies	265
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction	262
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19	262
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma	262
Waning Immunity after the BNT162b2 Vaccine in Israel	262
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension	260
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation	259
Artificial Intelligence in Medicine	258
Changing the Orbit around Percutaneous Coronary Intervention for Stable Angina	257
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma	257
The Evolving Challenge of Infections in Cirrhosis	256
Is Xenotransplantation Ready for Prime Time?	256